Φορτώνει......
Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli
BACKGROUND: Ciprofloxacin, a fluoroquinolone, targets two essential bacterial enzymes, DNA gyrase and topoisomerase IV. Plasmid-borne qnr genes, encoding proteins that protect DNA gyrase and topoisomerase IV from inhibition by fluoroquinolones, contribute to resistance development. However, the pres...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Antimicrob Chemother |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890660/ https://ncbi.nlm.nih.gov/pubmed/29106520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx375 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|